Evidence map›Paper›PMID 42180140›Full record

ArticleJournal of parasitology research2026

The Impact of

Irdayanti Irdayanti, Hijral Aswad, Puji B S Asih, Ismail E Rozi, Herdiana Herdiana, Ajib Diptyanusa, Helen D Prameswari, Yenni Yusuf, Bahrani Bahrani, Najdah Hidayah and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of parasitology research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The Impact ofJournal of parasitology research · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Irdayanti IrdayantiMaster Program, Department of Biochemistry, Faculty of Mathematics and Natural Science, IPB University, Bogor, Indonesia, ipb.ac.id.ORCID https://orcid.org/0000-0003-1403-5266
Hijral AswadHasanuddin University Medical Research Center, Makassar, Indonesia.ORCID https://orcid.org/0009-0004-4432-1153
Puji B S AsihEijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia, brin.go.id.ORCID https://orcid.org/0000-0002-4582-9133
Ismail E RoziEijkman Research Center for Molecular Biology, National Research and Innovation Agency, Cibinong, Indonesia, brin.go.id.ORCID https://orcid.org/0000-0003-4930-5123
Herdiana HerdianaWorld Health Organization, Country Office for Indonesia, Jakarta, Indonesia, who.int.ORCID https://orcid.org/0000-0002-7260-3682
Ajib DiptyanusaWorld Health Organization, Country Office for Indonesia, Jakarta, Indonesia, who.int.ORCID https://orcid.org/0000-0002-1860-0923
Helen D PrameswariMalaria Teamwork, Ministry of Health, Jakarta, Indonesia, behdasht.gov.ir.ORCID https://orcid.org/0009-0007-7019-0857
Yenni YusufHasanuddin University Medical Research Center, Makassar, Indonesia.ORCID https://orcid.org/0000-0001-7310-6381
Bahrani BahraniDepartment of Parasitology, Faculty of Medicine, Hasanuddin University, Makassar, Indonesia, unhas.ac.id.ORCID https://orcid.org/0009-0004-1662-7518
Najdah HidayahBiomedical Science Study Program, Graduate School of Hasanuddin University, Makassar, Indonesia.ORCID https://orcid.org/0000-0002-9811-2080
I Made ArtikaDepartment of Biochemistry, Faculty of Mathematics and Natural Sciences, IPB University, Bogor, Indonesia, ipb.ac.id.ORCID https://orcid.org/0000-0003-4293-3389
Din SyafruddinHasanuddin University Medical Research Center, Makassar, Indonesia.ORCID https://orcid.org/0000-0001-7141-2545

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The efficacy of antimalarial treatment, particularly artemisinin-based combination therapy (ACT), continues to face persistent threats due to the development of drug resistance in

Indexed as

copy number variationdihydroartemisinin–piperaquine (DHA-PPQ)Plasmodium falciparumPlasmodium falciparum multidrug resistance-1 (Pfmdr1)

Identifiers

PMID42180140
PMCPMC13191822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.